Short description
Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic.
Description
Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic diseases. Located in Cambridge, Massachusetts, Ataxion was founded in April 2013 out of the Atlas Venture seed program by Dr. Josh Resnick and Atlas Venture Development Corporation Managing Director and Ataxion Board Member David Grayzel, MD.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America
Founded on
April 1, 2013
Exited on
March 7, 2017
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
Absolutely Noaccess, Blurry Noaccess
Sign in for full access
Founders
Joshua Resnick